Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
about
Towards Stratified Medicine in Plasma Cell MyelomaIdentification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma.Flow cytometry remission by Ig light chains ratio is a powerful marker of outcome in multiple myeloma after tandem autologous transplant: a real-life studyLong non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer.Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patientsRelapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinomaLong non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.OAHG: an integrated resource for annotating human genes with multi-level ontologies.Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors.IntNetLncSim: an integrative network analysis method to infer human lncRNA functional similarity.Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphomaConstruction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.The Evolution of Prognostic Factors in Multiple Myeloma.A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinomaA novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.Potential prognostic long non-coding RNA identification and their validation in predicting survival of patients with multiple myeloma.LncRNA-ANCR regulates the cell growth of osteosarcoma by interacting with EZH2 and affecting the expression of p21 and p27.Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer.Long non-coding RNAs in B-cell malignancies: a comprehensive overview.A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma.A six-long non-coding RNAs signature as a potential prognostic marker for survival prediction of ER-positive breast cancer patients.Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.Identification of long non-coding RNAs biomarkers for early diagnosis of myocardial infarction from the dysregulated coding-non-coding co-expression network.Analysis of long non-coding RNA expression profiles identifies novel lncRNA biomarkers in the tumorigenesis and malignant progression of gliomas.Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinomaA potential panel of two-long non-coding RNA signature to predict recurrence of patients with laryngeal cancer.Transcriptome analysis reveals dysregulated long non-coding RNAs and mRNAs associated with extrahepatic cholangiocarcinoma progression.Expression profiles analysis of long non-coding RNAs identified novel lncRNA biomarkers with predictive value in outcome of cutaneous melanoma.Identification of potential long non-coding RNA biomarkers associated with the progression of colon cancer.Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.Long non-coding RNA NEAT1 regulates E2F3 expression by competitively binding to miR-377 in non-small cell lung cancer.LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression.Measuring disease similarity and predicting disease-related ncRNAs by a novel method.Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma.
P2860
Q28074994-F11ABF94-249D-46EC-B5FE-DC981EC6A381Q33919936-4DF4EEEC-5FAF-4085-956E-A44E994A6F27Q36705534-98F40739-1280-4CF0-874B-1C527D83873CQ36976091-AB1D5EAC-CCC3-4A6A-A596-A449B16B245AQ36996542-7775B6AE-ED68-4404-A06A-AAB7E54A43EDQ37022234-7439B6EF-A9BE-4841-8E58-9DFB97CB57E3Q37159825-CBF6B145-FD91-44B6-BEEB-6592BC42D1DCQ37301923-149A5E87-68AF-4AA5-970B-EB1B0543B93EQ37307816-12429B4D-7992-4F42-B8E5-E27D83CFA8FBQ37310783-6009296F-0E7A-48E7-98F8-F932A94B58D0Q37362685-96A5198E-A195-4E22-840E-98CF1D64B352Q37373624-1BDB705D-7DE6-443C-9894-56C840881966Q37565302-4249079F-74F5-4A00-B671-21DB3FE0C44EQ37595680-253B09DE-2F7A-4E95-A08D-3F9D3DA98CFEQ37636634-F0F27B30-E5C7-409F-A622-05A1C2EDB6EDQ37683483-C02CB5A8-80ED-449F-8CD2-3C307669B77DQ37705864-FF202A27-9E2C-4DC1-A56C-B84F08E2F336Q37716461-93EDC30D-8B78-45D5-BB3B-EA94E3771EFEQ38905792-2B9D7C1E-484F-4E11-84C8-795B19CCB097Q40257510-259F3AA1-CFAB-491F-843D-3FFDA8ACF472Q40954417-F7C1D25E-5C16-4E39-AF38-21ED4C198D3EQ41233998-2F6AA996-7BE9-4BF8-87EB-8EAFC658B5DDQ41694305-1FD5FBF1-61FE-46B0-859F-FE2C5F73765EQ41709267-73684138-6BE2-479B-9B41-F841986FA22CQ42128391-0A551415-779D-400B-BF92-F45CEC83ECB9Q42273391-EEA7CA1A-6C0C-499E-93BA-46FEF74BE1FCQ42317549-42CDBD99-B1A1-46D0-8777-4C68903DDD84Q42366572-1039E238-70EC-43B1-98B1-6B4EEA98D374Q42366627-6354A3F8-959B-48CF-B833-60C9D8999FF9Q42371601-8A7DE4A5-7F58-49A7-A548-E990213568F5Q42378366-BDCB5C0B-1E19-4F63-BCBC-5FE796EAE264Q43128540-5728EA59-8C62-4929-833C-85353796BA2FQ43451695-9084B676-F66C-4543-9831-21294D62E4E6Q44279014-AA767A24-2095-4A59-B76E-A45F38A38BFDQ46988503-00048FFB-CF2A-4001-85AC-CBA9DD2CC9B0Q47137671-F37D4ED3-2C0C-44BA-BF48-10B459E7A658Q47143921-3F6F39B4-58D1-4427-ACC6-A5F60D717E1DQ47145939-29F04D58-9ECD-4BCE-82AA-A45EE11DF5E3Q47148401-C6AB304B-ED44-4A64-9976-B8199E6694ACQ47155278-E1F73571-0F7B-4BA4-AE1B-87AE6CDA48C0
P2860
Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification and validation ...... atients with multiple myeloma.
@ast
Identification and validation ...... atients with multiple myeloma.
@en
type
label
Identification and validation ...... atients with multiple myeloma.
@ast
Identification and validation ...... atients with multiple myeloma.
@en
prefLabel
Identification and validation ...... atients with multiple myeloma.
@ast
Identification and validation ...... atients with multiple myeloma.
@en
P2093
P2860
P50
P1476
Identification and validation ...... patients with multiple myeloma
@en
P2093
Haixiu Yang
Hengqiang Zhao
Hongbo Shi
Zhenzhen Wang
P2860
P2888
P356
10.1186/S13046-015-0219-5
P577
2015-09-11T00:00:00Z
P5875
P6179
1031784936